Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-23 Sale |
2024-09-24 9:01 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,983,257 | $11.79 | $23,382,600 | 32,843,727 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,276 | $4.4 | $84,814 | 1,164,009 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
21,053 | $3.07 | $64,633 | 1,183,285 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Tax Withholding |
2025-03-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.97 | 17,305,656 (Direct) |
View |
Ownership |
2025-03-06 4:07 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Gline Matthew Director 10% Owner |
0 | $0 | 38,847,462 (Indirect) |
View |
| 2025-02-20 Tax Withholding |
2025-02-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.72 | 17,316,601 (Direct) |
View |
| 2025-01-20 Tax Withholding |
2025-01-22 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,623 | $11.15 | 17,327,546 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.57 | 17,339,169 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.49 | 17,350,114 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.92 | 17,361,059 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,550,000 | $3.85 | 32,843,727 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,550,000 | $0 | 32,843,727 (Direct) |
View |
| 2024-09-20 Tax Withholding |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.97 | 32,843,727 (Direct) |
View |
| 2024-09-23 Other |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
498,539 | $11.97 | 32,843,727 (Direct) |
View |
| 2024-08-20 Tax Withholding |
2024-08-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,947 | $11.48 | 18,314,745 (Direct) |
View |
| 2024-07-26 Option Award |
2024-07-30 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
17,204,821 | $0 | 18,325,692 (Direct) |
View |
| 2024-07-20 Tax Withholding |
2024-07-25 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11 | 1,120,871 (Direct) |
View |
| 2024-06-20 Tax Withholding |
2024-06-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.8 | 1,131,816 (Direct) |
View |
| 2024-05-20 Tax Withholding |
2024-05-22 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.37 | 1,142,761 (Direct) |
View |
| 2024-04-20 Tax Withholding |
2024-04-23 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.46 | 1,153,706 (Direct) |
View |
| 2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
390,579 | $0 | 1,164,651 (Direct) |
View |
| 2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
994,373 | $6.4 | 1,164,651 (Direct) |
View |
| 2024-03-30 Tax Withholding |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
215,991 | $10.54 | 1,164,651 (Direct) |
View |
| 2024-03-20 Tax Withholding |
2024-03-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.01 | 990,063 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-22 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.54 | 1,001,008 (Direct) |
View |
| 2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.35 | 1,011,953 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
47,351 | $11.5 | 4,195,421 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
38,453 | $0 | 4,195,421 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
85,232 | $6.4 | 4,195,421 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
22,043 | $11.58 | 4,195,421 (Direct) |
View |
| 2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $9.96 | 1,006,488 (Direct) |
View |
| 2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,318 | $8.68 | 1,028,751 (Direct) |
View |
| 2023-10-24 Other |
2023-10-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
12,489 | $8.99 | 1,041,240 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
47,351 | $11.5 | 4,441,820 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
17,762 | $0 | 4,441,820 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
28,411 | $6.4 | 4,441,820 (Direct) |
View |
| 2023-09-28 Other |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,243 | $12.67 | 4,441,820 (Direct) |
View |
| 2023-09-22 Other |
2023-09-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,227 | $10.19 | 1,044,948 (Direct) |
View |
| 2023-08-27 Exercise |
2023-08-29 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
12,088 | $0 | 2,244,979 (Direct) |
View |
| 2023-05-27 Exercise |
2023-08-29 9:31 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
28,410 | $6.4 | 2,244,979 (Direct) |
View |
| 2023-08-28 Other |
2023-08-29 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
6,784 | $11.25 | 2,244,979 (Direct) |
View |
| 2023-08-22 Other |
2023-08-24 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,015 | $10.83 | 1,050,659 (Direct) |
View |
| 2023-08-02 Other |
2023-08-03 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,749 | $11.79 | 1,062,408 (Direct) |
View |
| 2023-07-27 Exercise |
2023-07-31 9:33 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
23,149 | $0 | 2,198,834 (Direct) |
View |
| 2023-07-27 Exercise |
2023-07-31 9:33 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
56,821 | $6.4 | 2,198,834 (Direct) |
View |
| 2023-07-24 Other |
2023-07-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,146 | $10.99 | 1,050,405 (Direct) |
View |
| 2023-06-22 Other |
2023-06-26 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,863 | $10.01 | 1,061,268 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
53,281 | $0 | 2,284,781 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
170,464 | $6.4 | 2,284,781 (Direct) |
View |
| 2023-05-31 Other |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
30,266 | $9.09 | 2,284,781 (Direct) |
View |
| 2023-05-23 Other |
2023-05-25 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
18,972 | $9.58 | 1,057,225 (Direct) |
View |
| 2023-04-20 Tax Withholding |
2023-04-24 9:28 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,375 | $8.8 | 1,057,225 (Direct) |
View |
| 2023-03-23 Other |
2023-03-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
18,563 | $7.3 | 1,095,163 (Direct) |
View |
| 2023-02-22 Other |
2023-02-24 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
14,471 | $8.43 | 1,109,634 (Direct) |
View |
| 2023-01-24 Other |
2023-01-26 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
15,594 | $8.56 | 1,125,228 (Direct) |
View |
| 2022-12-23 Other |
2022-12-28 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,408 | $7.1 | 1,144,636 (Direct) |
View |
| 2022-11-20 Other |
2022-11-22 6:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,373 | $5 | 1,164,009 (Direct) |
View |